As of May 25
| +0.20 / +2.13%|
The 5 analysts offering 12-month price forecasts for Lexicon Pharmaceuticals Inc have a median target of 24.00, with a high estimate of 40.00 and a low estimate of 9.00. The median estimate represents a +149.74% increase from the last price of 9.61.
The current consensus among 8 polled investment analysts is to Hold stock in Lexicon Pharmaceuticals Inc. This rating has held steady since May, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.